Variant report
Variant | nsv947646 |
---|---|
Chromosome Location | chr10:59189104-59218970 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs187237412 | chr10:59217438-59217439 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs191725757 | chr10:59217455-59217456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs181737374 | chr10:59217553-59217554 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs569698306 | chr10:59217558-59217559 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs536780354 | chr10:59217594-59217595 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs75965913 | chr10:59217599-59217600 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs576473325 | chr10:59217625-59217626 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs534329204 | chr10:59217633-59217634 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs570590644 | chr10:59217635-59217636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs76751382 | chr10:59217640-59217641 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs574665615 | chr10:59217673-59217674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs541974344 | chr10:59217734-59217735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs185306352 | chr10:59217771-59217772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs575670962 | chr10:59217798-59217799 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs546366075 | chr10:59217801-59217802 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs531726620 | chr10:59217841-59217842 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs145370928 | chr10:59217902-59217903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs549880199 | chr10:59217933-59217934 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs74855366 | chr10:59217940-59217941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs547016464 | chr10:59218000-59218001 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs562376716 | chr10:59218083-59218084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs372633315 | chr10:59218091-59218092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs190071162 | chr10:59218109-59218110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs568065397 | chr10:59218118-59218119 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs376671126 | chr10:59218162-59218163 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs551136583 | chr10:59218174-59218175 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs116606676 | chr10:59218175-59218176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs74697160 | chr10:59218239-59218240 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs78885139 | chr10:59218240-59218241 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs545465260 | chr10:59218248-59218249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs565541777 | chr10:59218315-59218316 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs536742580 | chr10:59218329-59218330 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs140793231 | chr10:59218334-59218335 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs10826037 | chr10:59218348-59218349 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs534292328 | chr10:59218350-59218351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs552710793 | chr10:59218384-59218385 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs528652958 | chr10:59218410-59218411 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs1011763 | chr10:59218495-59218496 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs557115172 | chr10:59218496-59218497 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs575549214 | chr10:59218545-59218546 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs546029968 | chr10:59218584-59218585 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs114084777 | chr10:59218647-59218648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs61847391 | chr10:59218694-59218695 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs540596348 | chr10:59218720-59218721 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs144768469 | chr10:59218736-59218737 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs529590423 | chr10:59218738-59218739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs5017754 | chr10:59218748-59218749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs76702085 | chr10:59218754-59218755 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs116291288 | chr10:59218773-59218774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs115033082 | chr10:59218798-59218799 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Obesity | 21956041 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Autism | 20841430 | CNVD |
Mental retardation | 17124404 | CNVD |
Epilepsy | 20923578 | CNVD |
Prostate cancer | 16573809 | CNVD |
Schizophrenia | 19329560 | CNVD |
Heart failure | 18772530 | CNVD |
Heart failure | 18854381 | CNVD |
Hyperglycemia | 19060297 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Usher syndrome | 20538994 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
small cell lung cancer | 17426248 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:59217400-59218400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
2 | chr10:59217400-59218600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
3 | chr10:59217600-59218200 | Enhancers | H1 Cell Line | embryonic stem cell |
4 | chr10:59217600-59218400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr10:59217800-59218200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr10:59217800-59218600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
7 | chr10:59218400-59219400 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |